Skip to main content

Natera Inc

For the period ended Dec 31, 2024. Filed Feb 28, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Feb 28, 2025

NTRA$311.98-2.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Statements of Stockholders’ Equity

  • (in thousands)*
​​​​​​​​​​​​​​​​​​
​ · ​ · Common Stock · ​ · AdditionalPaid-in · ​ · ​ · Accumulated Other Comprehensive · ​ · Accumulated Deficit · ​ · TotalStockholders'Equity
​ · Shares · Amount · Capital · ​ · ​ · Income (Loss) · ​ · ​
Balance as of December 31, 2021​95,140​​10​​2,050,417​​(2,287)​​(1,394,836)​​653,304
Issuance of common stock upon exercise of stock options​828​​—​​6,411​​—​​—​​6,411
Issuance of common stock under employee stock purchase plan​437​​—​​13,037​​—​​—​​13,037
Vesting of restricted stock​1,480​​—​​—​​—​​—​​—
Stock-based compensation​—​​—​​152,384​​—​​—​​152,384
Unrealized loss on available-for sale securities​—​​—​​—​​(14,075)​​—​​(14,075)
Issuance of common stock for public offering, net​13,145​​1​​433,191​​—​​—​​433,192
Issuance of common stock for IPR&D milestone​225​​—​​9,290​​—​​—​​9,290
Net loss​—​​—​​—​​—​​(547,799)​​(547,799)
Balance as of December 31, 2022​111,255​​11​​2,664,730​​(16,362)​​(1,942,635)​​705,744
Issuance of common stock upon exercise of stock options​298​​—​​3,892​​—​​—​​3,892
Issuance of common stock under employee stock purchase plan​392​​—​​15,128​​—​​—​​15,128
Issuance of stock for bonuses​349​​—​​19,774​​—​​—​​19,774
Issuance of common stock for IPR&D milestone​336​​—​​14,435​​—​​—​​14,435
Issuance of common stock for public offering, net​4,550​​—​​235,441​​—​​—​​235,441
Vesting of restricted stock units​2,401​​—​​—​​—​​—​​—
Stock-based compensation​—​​—​​192,437​​—​​—​​192,437
Unrealized gain on available-for sale securities​—​​—​​—​​13,277​​—​​13,277
Net loss​—​​—​​—​​—​​(434,801)​​(434,801)
Balance as of December 31, 2023​119,581​$11​$3,145,837​$(3,085)​$(2,377,436)​$765,327
Issuance of common stock upon exercise of stock options​1,626​​—​​12,988​​—​​—​​12,988
Issuance of common stock under employee stock purchase plan​369​​—​​17,298​​—​​—​​17,298
Issuance of stock for bonuses​270​​—​​24,071​​—​​—​​24,071
Issuance of common stock for Convertible Notes and accrued interest​7,532​​1​​286,729​​—​​—​​286,730
Vesting of restricted stock units​3,268​​—​​—​​—​​—​​-
Stock-based compensation​—​​—​​276,691​​—​​—​​276,691
Unrealized gain on available-for sale securities​—​​—​​—​​2,741​​—​​2,741
Net loss​—​​—​​—​​—​​(190,426)​​(190,426)
Balance as of December 31, 2024​132,646​$12​$3,763,614​$(344)​$(2,567,862)​$1,195,420
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.